Viimeisimmät kokeilut

EudraCT Number: 2004-004787-74

Sponsor Protocol Number: Final protocol

Start Date: 2005-04-19

Sponsor Name: Royal Group of Hospitals Trust

Full Title: A double blind, prospective, randomised, controlled clinical trial to evaluate the effect of topical phenytoin, on healing, in diabetic foot ulcers.

Medical condition: Diabetes Mellitus and associated diabetic foot ulceration

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2004-002069-19

Sponsor Protocol Number: 333369-EPY-2003

Start Date: 2005-04-19

Sponsor Name: Janssen-Cilag International NV

Full Title: A Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of RWJ-333369 as Adjunctive Therapy in Subjects with Refractory Partial Seizures

Medical condition: Refractory partial epilepsy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) BE (Completed) ES (Ongoing)

Trial results: View results

EudraCT Number: 2005-000043-28

Sponsor Protocol Number: E05-001

Start Date: 2005-04-19

Sponsor Name: ALEXION PHARMACEUTICALS INCORPORATED

Full Title: A Phase III, Open-Label, Extension Study of Eculizumab in Patients with Transfusion Dependent, Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Participated in the TRIUMPH (C04-001), SH...

Medical condition: paroxysmal nocturnal hemoglobinuria

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10034042		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) IE (Completed) SE (Completed) DE (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-004088-31

Sponsor Protocol Number: B4Z-XM-LYDM

Start Date: 2005-04-19

Sponsor Name: Lilly S.A.

Full Title: A Randomized Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety of Atomoxetine up to 12 weeks in Newly Diagnosed Children and Adolescents Outpatients with Attention-Deficit/Hyp...

Medical condition: Attention-Deficit/Hyperactivity Disorder

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10037175 - Psychiatric disorders	10003736	Attention deficit/hyperactivity disorder	PT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2004-002724-17

Sponsor Protocol Number: 02-NDOL-006

Start Date: 2005-04-19

Sponsor Name: Fresenius Kabi Deutschland GmbH

Full Title: Efficacy of Neodolpasse™ in the treatment of postoperative pain: Morphine sparing effect during the first 24 hours postoperatively after unilateral total hip arthroplasty.

Medical condition: Patients with ASA classification I-III, female or male between 18 and 85 years of age, undergoing primary cementless unilateral total hip arthroplasty

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed)

Trial results: View results

EudraCT Number: 2005-000872-41

Sponsor Protocol Number: BGP-15-CLIN-IR01

Start Date: 2005-04-19

Sponsor Name: N-Gene Research & Development Ltd.

Full Title: RANDOMIZED DOUBLE-BLIND, MULTIPLE DOSE, PLACEBO-CONTROLLED STUDY TO DETERMINE THE INSULIN SENSITIZING EFFECT OF BGP-15 IN PATIENTS WITH INSULIN RESISTANCE

Medical condition: The metabolic syndrome is characterized by central obesity, atherogenic dyslipidemia, insulin resistance or glucose intolerance; prothrombotic state; raised blood pressure, proinflammatory state

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: HU (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001403-35

Sponsor Protocol Number: DOM2004 REDOX

Start Date: 2005-04-18

Sponsor Name: Doctor Pere Domingo

Full Title: Estudio abierto, multicéntrico y aleatorizado sobre la eficacia y seguridad de la reducción de dosis de estavudina en pacientes en tratamiento antirretroviral que incluye estavudina a dosis estánda...

Medical condition: AIDS

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001124-20

Sponsor Protocol Number: PCOS-5

Start Date: 2005-04-18

Sponsor Name: Sigrun Kjøtrød

Full Title: Metformin treatment before IVF/ICSI in normal weight women with polycystic ovarian syndrome. A European, prospective, randomised, double blind, multicenter study.

Medical condition: Polycystic ovary syndrome (PCOS) is a disorder characterized by polycystic ovaries, oligo-amenorrhea and hyperandrogenism. It is the most common endocrine disorder in women of fertile age. PCOS wom...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Female

Trial protocol: DK (Completed) SE (Completed) FI (Completed) GB (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-004415-29

Sponsor Protocol Number: DU176b-PRT007

Start Date: 2005-04-18

Sponsor Name: Daiichi Medical Research Inc

Full Title: A Phase IIa, multi-center, multi-national, open-label, dose ranging study of the efficacy, safety, and tolerability of oral DU-176b administered once or twice daily in the treatment of adult patien...

Medical condition: Prophylaxis of venous thromboembolism

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.1		10049909		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) LV (Completed)

Trial results: View results

EudraCT Number: 2004-005051-34

Sponsor Protocol Number: 42-73-305 / WIL1-0305

Start Date: 2005-04-18

Sponsor Name: LFB BIOTECHNOLOGIES

Full Title: Efficacy and safety study of vWF SD-35-DH (WILFACTIN) in children under 6 years of age

Medical condition: Von Willebrand disease

Disease:	Version	SOC Term	Classification Code	Term	Level
			10047715

Population Age: Newborns, Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: View results

Viimeisimmät kokeilut

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot